MannKind (MNKD) investors saw Afrezza scripts come in for the week of 11/10 slightly higher than the previous week, but essentially flat. This is a period where traction is needed if MannKind hopes to hit the re-stated low end of net revenue guidance of $6 million. Simply stated, the company needs sales to ramp up substantially in a time period where it is typically tough to demonstrate sales traction with prescription drugs. The data this week is the first data that includes the potential impacts of the regional television advertising campaign launched by MannKind on November 6th. Ad campaigns take time to bring about maximum effectiveness, so investors should not anticipate or expect an overnight shift in script sales. In the near term, patients with existing appointments that see the ad may be compelled to ask their doctor about Afrezza. In the longer term, the benefit may grow because the advertisement may compel a patient to schedule an appointment and inquire. One challenge that remains is that insurance coverage on Afrezza is far from optimal, and while a patient may ask about the drug, they may not act on it after getting a script because of a lack of coverage or the level of out of pocket expense. Like anything, there are positives and negatives to consider so that you as an investor can arrive at a realistic assessment and opinion.
Best Heal Care Stocks To Buy For 2018: Tandy Leather Factory, Inc.(TLF)
- [By Lee Jackson]
These companies also reported insider buying last week: Armour Residential REIT Inc. (NYSE: ARR), Ducommun Inc. (NYSE: DCO), PJT Partners Inc. (NYSE; PJT), Sonic Automotive Inc. (NYSE: SAH)and Tandy Leather Factory Inc. (NASDAQ: TLF).
Best Heal Care Stocks To Buy For 2018: Deer Valley Corporation (DVLY)
- [By SEEKINGALPHA.COM]
Deer Valley (OTCPK:DVLY)
This company manufactures factory-made homes which are marketed to 14 states in the US. After the financial crisis it has been able to pick up its operations and continue to create sustainable free cash flow and increasing profits. It might be that another similar shock to housing is not necessarily around the corner and therefore they could sustain this in the foreseeable future.
Best Heal Care Stocks To Buy For 2018: Core Laboratories N.V.(CLB)
- [By Lisa Levin] Gainers
Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) shares rose 18.4 percent to $68.65 in pre-market trading as the company reported upbeat results for its first quarter.
Jack in the Box Inc. (NASDAQ: JACK) shares rose 9.5 percent to $111.60 in the pre-market trading session after the company posted better-than-expected earnings for its second quarter. The company also disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba.
Coherus Biosciences Inc (NASDAQ: CHRS) rose 9.8 percent to $24.20 in pre-market trading. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision.
Qiwi PLC (NASDAQ: QIWI) rose 8.1 percent to $21.49 in pre-market trading after reporting strong quarterly results.
Korea Electric Power Corporation (ADR) (NYSE: KEP) shares rose 7.9 percent to $20.00 in pre-market trading after dropping 4.33 percent on Tuesday
Target Corporation (NYSE: TGT) shares rose 7.5 percent to $58.60 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
AngloGold Ashanti Limited (ADR) (NYSE: AU) rose 4.3 percent to $11.71 in pre-market trading after falling 0.09 percent on Tuesday.
Colgate-Palmolive Company (NYSE: CL) rose 4.1 percent to $74.53 in pre-market trading after the NY Post reported that the company might be up for sale for $100 per share.
Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 4 percent to $2.35 in pre-market trading after declining 1.74 percent on Tuesday.
Core Laboratories N.V. (NYSE: CLB) rose 3.6 percent to $109.00 in pre-market trading after gaining 0.39 percent on Tuesday.
Clovis Oncology Inc (NASDAQ: CLVS) rose 3.2 percent to $51.15 in pre-market trading. JP Morgan upgraded Clovis Oncology from Neutral to Overweight.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
- [By Craig Jones]
Core Laboratories N.V. (NYSE: CLB) performed poorly and it is in the oil business. Cramer wouldn’t buy it, because he doesn’t want to recommend a stock in the oil and gas business.
- [By Matthew DiLallo]
Core Laboratories (NYSE:CLB) literally has its ear to the ground when it comes to deciphering what’s going on in the oil market. The company studies oil reservoirs, which tell it what’s happening with production, giving it a deep level of understanding on the supply side of the market. Core Labs takes what the reservoirs are saying, compares this with other data, and then blends it into an informed macro view of the oil market, which CEO David Demshur shared on the company’s recent quarterly earnings conference call. Here are five things he says the reservoirs are telling us about what’s really going on in the oil market.
Best Heal Care Stocks To Buy For 2018: IPG Photonics Corporation(IPGP)
- [By Dan Caplinger]
Monday began on a down note for the stock market, as the Dow Jones Industrials fell back down below the 20,000 level. Major market benchmarks finished with losses of 0.6% to 0.8%, and some market commentators attributed the declines to nervousness about the Trump administration’s actions to clamp down on immigration. Others noted that the latest reading of U.S. economic growth showed a 1.9% rise in gross domestic product for the fourth quarter, finishing the year with an overall GDP increase of just 1.6%, down a full percentage point from 2015’s growth. Despite the overall sullen mood in the market, some stocks gained ground, and GoPro (NASDAQ:GPRO), Movado Group (NYSE:MOV), and IPG Photonics (NASDAQ:IPGP) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.